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ABSTRACT 20 
BACKGROUND: Simple field tests are often used to assess functional mobility in 21 
clinical settings. Despite having many benefits, these tests are susceptible to 22 
measurement error and individual variation.  23 
OBJECTIVES: To examine the test-retest and absolute reliability of timed up and go 24 
test (TUG), five times sit-to-stand (FTSTS), stair climb test (SCT) and 6 minute walk 25 
(6MWT). 26 
METHODS: Over two sessions, thirty-five subjects (30-74 years), repeated the five 27 
tests approximately four weeks apart. Test-retest reliability (intraclass correlations 28 
[ICC]) and absolute reliability (95% limit of agreements [95% LOA]; standard error of 29 
measurement [SEM] and minimum detectable change [MDC]) were calculated.  30 
RESULTS: All five tests had high test-retest reliability (ICC > 0.95) although 31 
significant between session changes were present for the TUG and FTSTS (p < 0.05). 32 
FTSTS displayed the greatest measurement error whilst 95% LOA was the most 33 
conservative measure of absolute reliability.  34 
CONCLUSIONS: The results of this study indicate that the TUG, FTSTS, SCT and 35 
6MWT are reliable when performed four weeks apart. Furthermore, the inclusion of 36 
SEM, MDC and 95% LOA provides reference values to aid in identifying changes over 37 
time above those of measurement error and individual variation.  38 
 39 
KEYWORDS: TUG, FTSTS, Stair climb, 6MWT  40 
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1. INTRODUCTION 41 
 42 
Functional mobility is the ability of an individual to carry out everyday activities such 43 
as rising from a chair, walking to the shops or even putting on socks. As a result of 44 
ageing, declines in cardiorespiratory fitness, muscular strength and endurance, and/or a 45 
loss of balance [1, 2] can all occur, contributing to impaired functional mobility and 46 
health related quality of life in the individual [3]. Undergoing a major surgical 47 
procedure can equally have a debilitating effect on the individual with prolonged 48 
periods of immobilisation promoting acute insulin resistance, reduced body mass and 49 
muscle wasting [4]; all of which accentuate the decay in functional mobility further. 50 
 51 
The use of functional mobility tests remain a popular metric by which to assess changes 52 
in physical functioning in both clinical and ageing populations. Various tests have been 53 
developed to assess the various components which can impact on the mobility of an 54 
individual. For example, poor performance of the timed up and go test (TUG), which is 55 
considered a measure of both balance [5] and functional mobility [6], has been 56 
associated with increased incidences of falls in elderly populations [5] whilst the 6 57 
minute walk test (6MWT) distance has been associated with all-cause mortality in 58 
chronic heart failure patients [7]. An important aspect to these tests is that they often 59 
need only a short administration time and do not require specialist equipment making 60 
them assessable in a host of clinical settings, easy to administer and simple for the 61 
patient/client to perform. They do, however, have certain limitations as their sensitivity 62 
 4 
 
to change over longer periods is potentially compromised by the presence of 63 
measurement error and variation in individual performance.  64 
 65 
An understanding of the test-retest reliability is therefore imperative in interpreting the 66 
results of each specific test. Intraclass correlation coefficients (ICC) remain one of the 67 
most frequently used statistical methods for assessing test-retest reliability [8] however 68 
these only provide a measure of relative reliability and therefore provide no indication 69 
of measurement error. As a measure of absolute reliability, the standard error of 70 
measurement (SEM) allows measurement error to be displayed in the same units as the 71 
original measurement [9]. Additionally, the minimum detectable change (MDC) can be 72 
calculated as the smallest difference between repeated trials that is not due to chance 73 
variation [10].  74 
 75 
The aim of this study was therefore to establish the test-retest reliability and absolute 76 
reliability of four commonly used tests of functional mobility when repeated 77 
approximately four weeks apart. 78 
 79 
2. METHODS 80 
2.1. SUBJECTS 81 
A sample of 35 volunteers (18 males, 17 females) was recruited from the local 82 
community via advertisement for this study. Inclusion criteria included being an 83 
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apparently healthy male and female aged 30-75 years. Exclusion criteria included any 84 
history of cardiopulmonary conditions, any musculoskeletal and/or orthopaedic 85 
conditions, current injury, history of fracture within the last year, uncorrected visual 86 
impairment, recent history of dizziness or fainting, vestibular disorders and shortness of 87 
breath with minimum exertion. Participants were screened for eligibility through the 88 
completion of an institution approved pre-exercise medical questionnaire. All 89 
participants provided written informed consent, and the study was approved by the 90 
Department of Sport, Health and Exercise Human Ethics Committee and followed the 91 
principles outlined in the Declaration of Helsinki. 92 
 93 
2.2. EXPERIMENTAL DESIGN   94 
As the purpose of this study was to test the test-retest reliability of the four assessment 95 
measures rather than inter-rater reliability, all trials were conducted by a single tester; 96 
this ensured maximum consistency for data collection of each variable. Participants 97 
were required to attend two identical testing sessions separated by approximately four 98 
weeks. Both sessions were conducted at the same time of day in order to control for 99 
circadian variation and participants were asked to refrain from strenuous exercise in the 100 
24 hours preceding each visit. The order of testing was the TUG, followed by the five 101 
times sit to stand (FTSTS), stair climb test (SCT) and finally the 6MWT.  102 
 103 
1. TUG: From a plastic chair measuring 40 cm from the floor and 39 cm deep, 104 
participants were asked to stand from a seated position, walk 3 metres before turning 105 
180° and returning to the chair to sit down. Timing started with the count of “THREE, 106 
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TWO, ONE, GO” and ended when they had returned to the seated position. Participants 107 
were instructed to perform this ‘as quickly as possible but in a controlled manner’ with 108 
time taken measured in seconds [5].  109 
2. FTSTS: Using a chair as above, participants were instructed the aim of the test was to 110 
perform five sit to stand movements as fast as they could in a controlled safe manner. 111 
From an upright seated position with their back against the chair backrest and arms 112 
crossed over their chest, the test started with the count of “THREE, TWO, ONE, GO” 113 
[11].  114 
3. SCT: Using a set of freestanding wooden stairs which consisted of five steps (each 20 115 
cm high) and a supporting handrail, participants were required to climb to the top as 116 
quickly as possible in a controlled safe manner. The use of the handrails and walking 117 
aids was permitted if required. Participants were instructed  that the tested started with 118 
the count of “THREE, TWO, ONE, GO” with the participant beginning the ascent on 119 
“GO” and the test finishing once both feet were flat on the top step [12].  120 
4. 6MWT:  A 30 metre flat walking surface was set out with cones marking each 3 121 
metre interval with distinct markers at the start and end. Following a period of 10 122 
minutes seated rest, participants were instructed to walk as far and as fast as possible in 123 
6 minutes. Rest periods were permitted however time was not stopped. A standardised 124 
protocol was used in line with the guidelines provided by the ATS [13]. At the end of 125 
the 6 minutes, participants stopped when instructed with the total distance walked 126 
providing the primary outcome measure. Measures of heart rate (HR) and arterial 127 
oxygen saturation (SaO2) (Nonin Onyx finger pulse Oximeter, Nonin Medical Inc, 128 
Plymouth, Minnesota) were taken prior to (HRpre, SaO2pre) and immediately after the 129 
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6MWT (HRpost, SaO2post). Heart rate was measured at one minute intervals throughout 130 
the test allowing the average HR (HRave) to be calculated.  131 
 132 
For TUG, FTSTS, and SCT, following an unrecorded familiarisation trial, the mean of 133 
three trials were taken for analysis. A single trial per session was performed for the 134 
6MWT.     135 
 136 
2.3. STATISTICAL ANALYSIS 137 
 138 
All statistical analyses were conducted using SPSS Version 20 for windows (SPSS Inc., 139 
Chicago, Il, USA) with the exception of the Bland-Altman plots which were performed 140 
using SigmaPlot Version 12 (Systat Software, San Jose, CA, USA). Normality of data 141 
was assessed using the Shapiro-Wilks test and all data conformed to normal distribution 142 
allowing parametric statistical procedures to be used. Differences between the two 143 
testing sessions for each assessment measure were assessed using paired sample t-tests.  144 
 145 
Relative reliability was assessed using the ICC model 3 [14]. As the mean of three trials 146 
was used for the TUG, FTSTS and SCT, test-retest reliability was measured using 147 
ICC3,2 model. For the 6MWT, which involved a single trial each session the ICC3,1 148 
model was used. Absolute reliability was expressed using 95% limits of agreement 149 
(95% LOA) [15], SEM and minimum detectable change at a 95% confidence interval 150 
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(MDC95). The 95% LOA represents the expected range of difference scores for each 151 
test. The SEM allowed measurement error to be displayed in the same units as the 152 
original measurement and was calculated using the formula:  153 
SEM = SD x √ (1-ICC) 154 
where SD was the standard deviation for all observations from test sessions 1 and 2 and 155 
ICC was the reliability coefficient.  Measurement error was also expressed as a 156 
percentage of the mean (SEM%) using the formula: 157 
SEM% = (SEM/mean) x 100 158 
This represents the smallest change required to indicate real change in a group of 159 
participants. MDC95 was calculated to represent the magnitude of change required to 160 
exceed the anticipated measurement variation, measurement error and variability of 161 
participants with 95% confidence [10]. The formula used for calculating MDC95 was: 162 
MDC95 = SEM x 1.96 x √2 163 
where the value of 1.96 represents the 95% CI and √2 accounted for the added 164 
uncertainty in measurement associated with repeated trials. Statistical significance was 165 
set at p ≤ 0.05 for all tests. 166 
 167 
3. RESULTS 168 
 169 
Thirty-five participants (18 males and 17 females; age 54.6 ± 12.1 years [Range: 30-74 170 
years], height 170.9 ± 11.0 cm [Range: 145.6 - 195.6 cm], body mass 78.4 ± 17.8 kg 171 
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[Range: 43.0 ± 119.3 kg]) were recruited to this study. The mean number of days 172 
between trials was 27.9 ± 1.5 days [Range: 24 – 33 days]. Thirty one (17 males and 14 173 
females) of the 35 participants reported their self-reported physical activity level as 174 
either moderately active or active. Three participants (1 male and 2 females) were 175 
sedentary whilst one female reported their physical activity level as highly active. 176 
 177 
3.1. TUG, FTSTS AND SCT 178 
 179 
A mean percentage improvement in the performance time of TUG (3.4%; Range: -10.4 180 
to +16.0%), FTSTS (3.9%; Range: +20.5 to -23.7%) and SCT (1.7%; Range: +12.4 to -181 
0.3%) was seen between the first and second visit. The improvement however was only 182 
significant (p < 0.05) for the TUG and FTSTS (Table 1). The results relating to the both 183 
relative (ICC) and absolute reliability (LOA, SEM & MDC) of the TUG, FTSTS and 184 
SCT are displayed in Table 2. All three tests demonstrated good test-retest reliability 185 
with high ICCs ranging from 0.96 to 0.98. Out of the three tests, the SCT displayed the 186 
greatest absolute reliability with the SEM represented as a percentage of the mean being 187 
2.8% whilst the FTSTS had the greatest measurement error at 5.8% of the mean.  188 
 189 
When analysed based on gender, mean performance time for all three tests was faster in 190 
males (Table 1), however neither relative nor absolute reliability were greatly affected 191 
(Table 2). The magnitude of the ICCs for all three tests remained similar in males (ICCs 192 
= 0.97 to 0.98) and females (ICCs = 0.94 to 0.97) compared to when all participants 193 
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were combined (ICCs 0.96 to 0.98). In respects to absolute reliability, the greatest 194 
variability between genders was observed in the FTSTS. 195 
 196 
3.2. 6MWT 197 
 198 
A mean improvement of approximately 5.6 metres (+0.9%) was seen between the first 199 
and second visit although this was not significant (p > 0.05) (Table 3). No significant 200 
difference was seen between sessions for SaO2post, HRpre, HRpost or HRave however 201 
SaO2pre was significantly lower in session 2. The high ICC and narrow accompanying 202 
95% CI demonstrated good test-retest reliability for the 6MWT (Table 4). Furthermore, 203 
the values reported for both 95% LOA and MDC95 were similar whilst the SEM of 13.7 204 
metres (SEM% -2.3%) represented a low value of measurement error.   205 
 206 
When analysed based on gender, the mean distance walked was significantly further 207 
(+12.1 metres; +2.0%; p < 0.05) in the 2
nd
 session for males however no difference 208 
between sessions was evident for females (-1.2 metres; 0.2%; p > 0.05). Despite the 209 
difference in males between sessions neither the relative nor absolute reliability of the 210 
6MWT was greatly affected.  211 
 212 
4. DISCUSSION  213 
 214 
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The aims of this study were 1). to establish the test-retest reliability of four functional 215 
mobility tests often used within clinical studies when performed approximately four 216 
weeks apart and 2). to calculate LOA, SEM and MDC, giving an indication of absolute 217 
reliability between repeated tests. All four tests used in this study displayed good test-218 
retest reliability, exceeding the ICC threshold of 0.90 previously reported to be required 219 
for a clinical test [16]. Whilst the use of ICC provide an indication of the relative 220 
reliability of a test, the inclusion of a measure of absolute reliability is important in 221 
order to gain an understanding of whether real change has actually occurred. In the 222 
current study despite good test-retest reliability being seen for all the tests used, 223 
considerable individual performance variability was present for some tests (in particular 224 
the FTSTS), highlighting the need to incorporate both measures of relative and absolute 225 
agreement when assessing the reliability of a test [17].         226 
 227 
Of the four tests included in the current study, the 6MWT is probably the most 228 
frequently used acting as a means of assessing the effectiveness of different intervention 229 
programmes [18] as well as a predictor of both cardiorespiratory fitness [19] and 230 
clinical outcomes [7]. As in the current study, good test-retest reliability has been 231 
observed in a number of other populations including cardiac patients (ICCs = 0.88 - 232 
0.97) [20-22], type 2 diabetics (ICC = 0.99) [23] and the elderly (ICCs = 0.87 – 0.93) 233 
[24]. It is however often reported that at least one, if not more, familiarisation trials are 234 
required in order to alleviate any potential learning effect and thus achieve a consistent 235 
baseline measurement for the 6MWT [21, 22, 26, 27].  236 
 237 
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In healthy individuals aged 60-70; it was only from the third trial that the measurement 238 
became reliable when performing five 6MWT over a 1 week period [26]. Between both 239 
the 1st and 2nd, and 2nd and 3rd trials a mean increase of ~20 metres was reported; 240 
representing a 3.7 – 3.8% increase between trials. An average improvement of 8 ± 5% 241 
(+47 metres) in the second of two trials performed on the same day was observed in 242 
healthy individuals aged 50 - 85 years [27]. Both Hanson et al. [22] and Hamilton et al. 243 
[21] reported a learning effect occurred between trials within a cardiac rehabilitation 244 
setting despite reporting good relative reliability (ICC=0.91 and 0.97 respectively). An 245 
11.8% (+52 metres) increase in distance walked was observed in Hanson et al. [22] 246 
between the 1
st
 and 2
nd
 trial and this increased to 19.1% (+85 metres) between the 1
st
 247 
and 3
nd
 trial. Furthermore, whether the three tests were performed on the same day or 248 
spread over a week did not alter the presence of the learning effect [22]. Although the 249 
improvement was smaller, Hamilton et al. [21] observed a 3.5% (+18 metres) increase 250 
between the 1
st
 and 2
nd
 trial and 5.6% (+29 metres) between the 1
st
 and 3
nd
 trial. 251 
 252 
Whilst performing repeated trials of the 6MWT on the same day has been shown to be 253 
physically tolerable in clinical populations [26, 28], it may not always be feasible. In the 254 
current study only a 0.9% (+5.6 metres) increase was witnessed between trials when all 255 
participants were combined. Even in males alone, where a 2.0% (+12.1 metres) increase 256 
in distance walked was observed during the 2
nd
 trial compared to the 1
st
, the magnitude 257 
of the change was lower than some of the values previously reported [21, 26, 27]. This 258 
may indicate to a certain extent that any learning effect gained through previously 259 
performing the test may be attenuated by the longer period (4 weeks) between trials 260 
compared to those repeated over a shorter period of time (1 – 14 days) [21, 26, 27]. 261 
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Furthermore, the absence of a significant difference in HRpost, HRave or SaO2post between 262 
the sessions (Table 3) would suggest there was no increased or decreased physical effort 263 
exerted by participants during the 2
nd
 trial; potentially supporting the presence of an 264 
attenuated learning effect. 265 
 266 
It is acknowledged that direct comparisons between this study and those using clinical 267 
populations are difficult as considerable variation does exist between population groups. 268 
The SEM (13.7 metres) and MDC95 (37.8 metres) seen in the current study were 269 
comparable to those reported in older type 2 diabetics (SEM = 9.88 metres; MDC95 = 270 
27.37 metres) by Alfonsa-Rosa et al. [23]. This was despite only a 1 week period 271 
existing between their trials suggesting any learning effect was absent in their study 272 
[23]. These values however do differ from those seen in both elderly (SEM: 32-34 273 
metres; MDC95: 88.7-95 metres [24] and cardiac (SEM: 18.4-32.6 metres; MDC95: 274 
50.92 – 90.3 [20, 21, 29] populations therefore patient characteristics and conditions 275 
need to be considered in determining changes in performance.  276 
 277 
Unlike with the 6MWT, the presence of a significant statistical decrease in time taken to 278 
perform the TUG and FTSTS between the first and second sessions suggested a learning 279 
effect was present. Similar improved FTSTS performance times have previously been 280 
reported in trials separated by 4-10 days [30] up to six weeks [31, 32]. Despite this, the 281 
ICC for all three studies was in excess of 0.80 indicating good correlation and 282 
agreement between trials. The ICC of 0.97 for the TUG in the current study (Table 1) 283 
exceeded that of Jette et al. [33], who reported an ICC of 0.74 in elderly frail 284 
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individuals. However, the difference in study populations is likely to have influenced 285 
the reduced ICC in Jette et al. [33] compared to the current study. It is also worth noting 286 
that whilst the median number of days between trials was 14 days in Jette et al. [33], the 287 
overall range between trials varied from 0 days to 132 days. It is therefore plausible that 288 
the decrease in test-retest reliability, as indicated by ICC, was related to a true change in 289 
the study populations’ ability to perform the FTSTS; especially in the individuals with 290 
the largest number of days between trials.    291 
 292 
The results relating to the relative reliability of the FTSTS when performed with an 293 
extended period between trials have previously been varied [34]. In trials separated by 294 
4-10 days, Bohannon et al [30] reported good test-retest reliability (ICC = 0.96; 95% 295 
CI: 0.92-0.98) in community-dwelling men and women aged 15-85 years. In contrast, 296 
when the interval between trials has been longer, lower ICC’s have tended to be 297 
reported. In two studies by Schaubert and Bohannon [31, 32] in which testing sessions 298 
were separated by 6 weeks, ICCs of 0.82 (95% CI: 0.68-0.92) and 0.81 (95% CI: not 299 
stated) respectively were reported. In the current study, despite the 4 week period 300 
between tests, test-retest reliability remained good with the ICC of 0.96 far exceeding 301 
those seen in the two aforementioned studies.  302 
 303 
This difference could potentially be explained by a number of factors, including the 304 
presence of a shorter four week period between testing sessions in the current study as 305 
opposed to six weeks [31, 32]. Furthermore, the sample sizes used in both these studies 306 
(n=21 [31] and n=11 [32]) were smaller than those of the current study (n=35). A more 307 
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pertinent factor however is probably the difference in participant ages between the 308 
studies. It is acknowledged that the mean ages in both Schaubert and Bohannon studies 309 
[31, 32] (75.0 ± 5.9 years [Range: 65-85 years] and 75.5 ± 5.8 years [Range: 65-85 310 
years] respectively) make their findings more generalizable, especially to older 311 
populations where the FTSTS is more traditionally used, than the current study (54.6 ± 312 
12.1 years [Range: 30 -74 years]). Despite this, the current study adds to the existing 313 
literature with regards to the potential measurement error of the four tests investigated. 314 
 315 
Whilst TUG and FTSTS displayed good relative test-retest reliability in the current 316 
study, the absolute reliability for the tests did reflect the presence of considerable 317 
individual variation in the performance of each. Inconsistencies in the agreement of 318 
relative and absolute reliability measures have previously been observed making the use 319 
of a combined approach important [17]. The FTSTS was the most variable with a SEM% 320 
of 5.8% and MDC95% of 16.09%. These values were less than the SEM% of 6.3% and 321 
MDC95% of 17.5% reported by Goldberg et al. [11] when performing repeated trials on 322 
the same day in apparently healthy older female participants.  Furthermore Goldberg et 323 
al. [11] indicated a MDC95% of 17.5% may be considered a low minimum change 324 
percentage. Further variation existed in the level of absolute reliability depending on the 325 
measure by which it was assessed.  326 
 327 
The use of 95% LOA as a measure of absolute reliability in the current study reflected 328 
the most conservative method. For the FTSTS, 95% LOA suggested a change of over 329 
2.55 seconds was required to detect real change compared to the 1.60 seconds according 330 
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to the MDC95 (Table 2).  Understanding the variation present in both the performance of 331 
the test and the different methods of calculating absolute reliability could be important 332 
when assessing any change present in repeated performances.   333 
 334 
Although in the current study the SCT displayed good relative test-retest reliability 335 
(ICC = 0.98; 95% CI 0.95-0.99) and absolute reliability (SEM = 0.08 s; MDC95 = 0.22 336 
s), the results remain difficult to interpret. Variations of the SCT have been used in a 337 
variety of different populations including those with orthopaedic limitations and the 338 
elderly. The intra-session reliability in elderly individuals (mean age 69.4 years) with 339 
hip and/or knee osteoarthritis was reported to be good with an ICC of 0.94 (95% CI 340 
0.75-0.98) and SEM of 0.28 seconds seen for a four step ascent only SCT [12]. When 341 
performing a five step SCT including both the ascent and descent of the stairs two 342 
weeks apart, Rejeski et al. [35] reported good test- retest reliability (ICC = 0.93; 95% CI 343 
Not reported) in patients with knee osteoarthritis. Despite similar ICC being reported in 344 
Lin et al. [12], Rejeski et al. [35] and the current study, making comparisons between 345 
the studies is difficult. The absence of any limiting condition such as osteoarthritis in 346 
the present study that may have impaired the ability of participants to climb stairs, 347 
means the performance time of 2.77 seconds is faster than those reported in either Lin et 348 
al. [12] (4.17 ± 2.80 s) or Rejeski et al. [35] (10.21 ± 4.45 s). It is therefore 349 
acknowledged the SCT results are difficult to generalise beyond the present study.   350 
 351 
This study is not without limitations. The use of an apparently healthy population with a 352 
relatively wide age range (30-74 years) in this study means the results cannot be directly 353 
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generalised to those of a specific clinical population. Furthermore, given the sample 354 
size, stratification based on factors such as age, gender and self-reported physical 355 
activity was not possible. The sub-analysis based on gender alone (Tables 2 and 4) did 356 
not differ greatly between the genders for any of the tests in the current study, however 357 
whether a more pronounced difference would be observed with a larger sample size 358 
cannot be dismissed. 359 
 360 
Despite this, whilst reference values for the tests examined in the current study exist in 361 
many clinical and ageing populations where their use is potentially more suited, 362 
circumstances occur where these tests may be used outside of such populations meaning 363 
values such as those found in the current study remain important. The diagnosis of 364 
certain clinical conditions (e.g. some cancers) may occur across a wide age range whilst 365 
not always being accompanied by the presence of other co-morbidities or physiological 366 
limitations that some other clinical populations may experience. It is therefore necessary 367 
to have reference values to support the pre-existing literature and future studies relating 368 
to these age ranges. 369 
 370 
In conclusion, this study has demonstrated the test-retest reliability for the TUG, 371 
FTSTS, SCT and 6MWT exceeds the ICC threshold of above 0.90 that is required for a 372 
clinical test [16] when performed within a 4 week period between sessions in apparently 373 
healthy adults aged 30-74 years. Despite research already existing to the test-retest 374 
reliability of these tests, there is still limited data regarding measures of absolute 375 
reliability, especially when performed with weeks rather than days in between testing 376 
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sessions. Although not directly related to a specific clinical population, the presentation 377 
of measures of absolute reliability such as LOA, SEM and MDC95 in the current study 378 
adds valuable information to the existing literature. By providing further reference 379 
thresholds of absolute reliability, clinicians and researchers alike can use the 380 
information to identify meaningful changes beyond those due to measurement error and 381 
individual variability. This will aid in assessing the effectiveness of exercise 382 
interventions and rehabilitation programmes in settings where more sophisticated 383 
facilities and techniques may not be available.  384 
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Table 1. Between session performance differences for the Timed up and go (TUG), Five 487 
times sit to stand (FTSTS) and Stair climb test (SCT). 488 
  Session 1 
(SD) 
[Range] 
Session 2  
(SD) 
[Range] 
Mean difference  
(SD) 
[95% CI] 
P value 
TUG (s) Males (n=18) 
 
Females (n=17) 
 
Combined 
(n=35) 
 
5.98 (1.41) 
[4.20 - 8.89] 
6.46 (1.44) 
[4.21 - 9.21] 
6.21 (1.42) 
[4.20 - 9.21] 
5.70 (1.20) 
[4.01 - 8.60] 
6.31 (1.78) 
[4.12 - 8.41]  
6.00 (1.21) 
[4.01 - 8.60] 
-0.28 (0.38) 
[-0.46; -0.09] 
-0.15 (0.41) 
[-0.36; 0.06] 
-0.21 
[-0.35; -0.08] 
0.007 
 
0.159 
 
0.003 
FTSTS (s) Males (n=18) 
 
Females (n=17) 
 
Combined 
(n=35) 
 
10.96 (2.86) 
[6.20 - 17.50] 
11.87 (2.94) 
[6.45 - 19.64] 
11.40 (2.89) 
[6.20 - 19.64] 
10.61 (2.94) 
[5.76 - 17.87] 
11.33 (2.67) 
[7.07 - 17.74] 
10.96 (2.79) 
[9.27 - 17.87] 
-0.36 (0.38) 
[-0.75; 0.04] 
-0.54 (1.33) 
[-1.22; 0.14] 
-0.44  
[-0.81; -0.08] 
0.073 
 
0.113 
 
0.019 
SCT (s) Males (n=18) 
 
Females (n=17) 
 
Combined 
(n=35) 
2.79 (0.45) 
[2.13 - 3.68] 
2.85 (0.51) 
[1.93 - 3.69] 
2.82 (0.48) 
[1.93 - 3.69] 
2.73 (0.46) 
[2.03 - 3.61] 
2.80 (0.58) 
[1.71 – 3.83] 
2.77 (0.51) 
[1.71 - 3.83] 
-0.05 (0.11) 
[-0.11; -0.00] 
-0.04 (0.19) 
[-0.14; 0.05] 
-0.05 
[-0.10; +0.01 
 
0.048 
 
0.348 
 
0.061 
SD: standard deviation; 95% CI: 95% confidence intervals; s: seconds  
 489 
 490 
 491 
 492 
 493 
 494 
 495 
 24 
 
Table 2. Reliability data for the Timed up and go (TUG), Five times sit to stand 496 
(FTSTS) and Stair climb test (SCT).  497 
  ICC3,2 
[95% CI] 
95% LOA SEM SEM% MDC95 MDC95% 
TUG (s) Males (n=18) 
Females (n=17) 
 
Combined (n=35) 
0.97 (0.86 - 0.99) 
0.97 (0.92 - 0.99) 
 
0.97 [0.93 - 0.99] 
 
-1.02;  +0.47 
-0.95; +0.63 
 
-0.99; +0.56 
0.23 
0.22 
 
0.22 
 
3.89 
3.69 
 
3.67 
0.63 
0.60 
 
0.62 
 
10.79 
9.33 
 
10.18 
FTSTS (s) Males (n=18) 
Females (n=17) 
 
Combined (n=35) 
0.98 (0.94 - 0.99) 
0.94 (0.82 - 0.98) 
 
0.96 [0.91 - 0.98] 
 
-1.90; +1.19 
-3.14; +2.06 
 
-2.55; +1.66 
0.43 
0.71 
 
0.58 
3.94 
6.12 
 
5.19 
 
1.18 
1.96 
 
1.60 
10.92 
16.92 
 
16.09 
SCT (s) Males (n=18) 
Females (n=17) 
 
Combined (n=35) 
0.98 (0.95 - 0.99) 
0.97 (0.92 - 0.99) 
 
0.98 [0.95 - 0.99] 
 
-0.27; +0.16 
-0.41; +0.33 
 
-0.34; +0.25 
0.06 
0.09 
 
0.08 
 
2.13 
3.32 
 
2.80 
0.16 
0.26 
 
0.22 
 
5.91 
9.21 
 
7.77 
ICC: Intraclass correlation; 95% CI: 95% confidence interval; 95% LOA: 95% limit of agreements; SEM: Standard error of 
measurement; MDC95: Minimum detectable change at the 95% confidence interval 
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Table 3. Between session performance and physiological differences for the 6 minute 507 
walk test (6MWT). 508 
6 Minute Walk Test (6MWT) 
  Session 1 
(SD) 
[Range] 
Session 2  
(SD) 
[Range] 
Mean 
difference  
[95% CI] 
P value 
Distance  
walked (m) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
 
613.2 (73.9) 
[486 - 726] 
576.7 (78.3) 
[437 - 699] 
595.5 (77.2) 
[437 - 726] 
625.3 (86.9) 
[483 - 759] 
575.5 (75.1) 
[451 - 705] 
601.1 (84.1) 
[451 - 759] 
+12.1 (20.7) 
[1.8; 22.4] 
-1.2 (14.5) 
[-8.7; 6.2] 
+5.6 (18.9) 
[-0.87; +12.13] 
0.024 
 
0.729 
 
0.087 
HRpre 
(bpm) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
 
68.1 (12.2) 
[52 - 94] 
72.3 (13.4) 
[52 - 98] 
70.1 (12.8) 
[52 - 98] 
69.7 (9.5) 
[54 - 84] 
68.6 (10) 
[52 – 88] 
69.1 (9.6) 
[52 - 88] 
1.6 (9.6) 
[-3.2; 6.4] 
-3.7 (9.3) 
[-8.5; 1.1] 
-1.0 (9.7) 
[-4.33; +2.33] 
0.503 
 
0.119 
 
0.546 
HRpost 
(bpm) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
107.4 (22.0) 
[78 - 165] 
112.4 (24.5) 
[76 - 166] 
109.8 (23.1) 
[83.5 - 157.0] 
110.6 (23.4) 
[71 – 161] 
110.7 (23.7) 
[80 – 159] 
110.6 (23.2) 
[71.0 - 161.0] 
13.2 (11.2) 
[-2.4; 8.6] 
-1.7 (6.2) 
[-4.9; 1.5] 
+0.8 (9.3) 
[-2.4; +4.0] 
0.248 
 
0.275 
 
0.616 
HRave 
(bpm) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
 
109.1 (20.1) 
[83.5 - 157.0] 
112.6 (16.8) 
[84 - 140] 
110.8 (18.4) 
[83.5 - 157.0] 
110.3 (21.2) 
[75 - 151]  
111.4 (17.2) 
[84 - 142] 
110.8 (19.1) 
[75.0 - 151.0] 
1.2 (7.9) 
[-2.7; 5.2] 
-1.3 (6.4) 
[-4.6; 2.0] 
+0.0 (7.2) 
[-2.5; +2.5] 
0.522 
 
0.420 
 
0.998 
SaO2pre 
(%) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
97.9 (1.0) 
[96 - 99] 
98.0 (1.1) 
[95 - 100] 
97.9 (1.0) 
[95 - 100] 
96.9 (1.6) 
[94 - 99] 
97.5 (1.6) 
[94 - 100] 
97.2 (1.7) 
[94 - 100] 
-1.0 (2.0) 
[-2.0; - 0.0] 
-0.5 (1.3) 
[-1.2; 0.3] 
-0.5 (1 
[-1.0; +0.5] 
0.046 
 
0.187 
 
0.073 
SaO2post 
(%) 
Males (n=18) 
 
Females (n=17) 
 
Combined (n=35) 
97.7 (1.5) 
[93 - 100] 
97.0 (2.6) 
[89 - 99] 
97.4 (2.1) 
[89 - 100] 
96.7 (1.8) 
[91 - 98] 
97.5 (2.2) 
[91 - 100] 
97.2 (2.0) 
[91 - 100] 
-0.9 (2.3) 
[-2.1; 0.2] 
0.5 (1.3) 
[-0.2; 1.3] 
-0.2 
[-0.9; +0.5] 
0.094 
 
0.135 
 
0.552 
HRpre: Heart rate prior to 6MWT; HRpost: Heart rate post 6MWT; HRave: Average heart rate; SaO2pre: 
Oxygen saturation prior to 6MWT; SaO2post: Oxygen saturation post 6MWT 
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Table 4. Reliability data for the 6 minute walk test (6MWT)  512 
  ICC3,2 
[95% CI] 
95% LOA SEM SEM% MDC95 MDC95% 
6MWT 
(m) 
Males (n=18) 
Females (n=17) 
 
Combined (n=35) 
0.96 (0.86 - 0.99) 
0.98 (0.95 - 0.99) 
 
0.97 [0.94 - 0.99] 
 
-28.4; +52.6 
-29.6; +27.1 
 
-31.4; +42.7 
16.3 
9.9 
 
13.7 
 
2.6 
1.7 
 
2.3 
45.3 
27.3 
 
37.8 
7.3 
4.7 
 
6.3 
ICC: Intraclass correlation; 95% CI: 95% confidence interval; 95% LOA: 95% limit of agreements; SEM: Standard error of 
measurement; MDC95: Minimum detectable change at the 95% confidence interval 
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